Projects per year
Personal profile
Research interests
- COVID-19
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Chien-Te Tseng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 60 Completed
-
SARS-CoV-2 tropism in the brain and its relationship to COVID-19 pathogenesis
University of North Dakota - Grand Forks
1/1/22 → 8/31/22
Project: Other project
-
-
-
Pilot lethality study of hACE2 transgenic mice against SARS-CoV-2 infection
1/15/21 → 7/15/21
Project: Other project
-
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine
Zhu, J., Jain, S., Sha, J., Batra, H., Ananthaswamy, N., Kilgore, P. B., Hendrix, E. K., Hosakote Madaiah, Y., Wu, X., Olano, J. P., Kayode, A., Galindo, C. L., Banga, S., Drelich, A., Tat, V., Tseng, C. T. K., Chopra, A. K. & Rao, V. B., Aug 2022, In: mBio. 13, 4Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
Ma, H., Guo, Y., Tang, H., Tseng, C. T. K., Wang, L., Zong, H., Wang, Z., He, Y., Chang, Y., Wang, S., Huang, H., Ke, Y., Yuan, Y., Wu, M., Zhang, Y., Drelich, A., Kempaiah, K. R., Peng, B. H., Wang, A., Yang, K., & 30 others, Dec 2022, In: Cell Discovery. 8, 1, 16.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
Mudrick, H. E., Massey, S., McGlinch, E. B., Parrett, B. J., Hemsath, J. R., Barry, M. E., Rubin, J. D., Uzendu, C., Hansen, M. J., Erskine, C. L., Van Keulen, V. P., Drelich, A., Panos, J. A., Fida, M., Suh, G. A., Peikert, T., Block, M. S., Tseng, C. T. K., Olivier, G. R. & Barry, M. A., Aug 2022, In: Science Advances. 8, 34, eabm8563.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays
Curreli, F., Ahmed, S., Victor, S. M. B., Drelich, A., Panda, S. S., Altieri, A., Kurkin, A. V., Tseng, C. T. K., Hillyer, C. D. & Debnath, A. K., Jan 2022, In: Viruses. 14, 1, 69.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Efficacy and self-similarity of SARS-CoV-2 thermal decontamination
Yap, T. F., Hsu, J. C., Liu, Z., Rayavara, K., Tat, V., Tseng, C. T. K. & Preston, D. J., May 5 2022, In: Journal of Hazardous Materials. 429, 127709.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations
Press / Media
-
Judicial Watch: Documents Show Texas Researcher Warned Wuhan Lab of COVID Investigation by Congress
5/10/22
1 item of Media coverage
Press/Media: Expert Comment
-
Texas Researcher Warned Wuhan Lab of COVID Investigation
5/10/22
1 item of Media coverage
Press/Media: Expert Comment
-
Rice lab details conditions to decontaminate disposable masks
11/12/21
1 item of Media coverage
Press/Media: Expert Comment
-
GNL animal studies support COVID-19 effectiveness of Adamis antioxidant drug
3/17/21
1 item of Media coverage
Press/Media: Expert Comment
-
-Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model
3/16/21
1 item of Media coverage
Press/Media: Expert Comment